Judge may report drug company executive to attorney generalBMJ 2004; 328 doi: https://doi.org/10.1136/bmj.328.7434.243 (Published 29 January 2004) Cite this as: BMJ 2004;328:243
- Clare Dyer, legal correspondent
A high court judge is considering reporting a senior executive of GlaxoSmithKline to the attorney general after he told an expert witness appearing for the company's opponents in a patent action that the company would not fund any research by him in the future.
Mr Justice Pumfrey, who was last week hearing a patent action brought against Glaxo by a group of generic drug companies over Seretide, its combined inhaler of salmeterol and fluticasone, called Dr Garth Rapeport before him for questioning.
The judge acted after Professor Clive Page, an asthma expert from King's College, London, who was appearing as a witness …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial